Overview

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

Status:
Recruiting
Trial end date:
2030-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to provide access to 18F-DOPA PET to patients at Washington University and assess the utility of 18F-DOPA PET/MRI as a preoperative tool to detect and localize focal lesions in the pancreas that are causing hyperinsulinism.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
St. Louis Children's Hospital
Treatments:
Dihydroxyphenylalanine